Medpace Holdings, Inc.
↗Cincinnati, Ohio, United States
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. Founded in 1992 and headquartered in Cincinnati, Ohio, Medpace operates across 46 countries with approximately 6,200 employees. The company specializes in integrated clinical trial management, regulatory affairs guidance, data management, bioanalytical laboratory services, and clinical imaging services. Medpace's business model emphasizes long-term client partnerships structured around full-service outsourcing rather than project-based work, enabling seamless execution of complex clinical development programs. The company has achieved significant growth, with 2025 revenue of $2.53 billion (20% YoY growth) and strong EBITDA margins exceeding 22%.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Contract Research Organization (CRO)
Sub-Industry:Full-Service Clinical CRO
SIZE & FINANCIALS
Employees:5001-10000
Revenue:$2.1B-$2.5B
Founded:1992
Ownership:public
Status:operating
FUNDING
Stage:Public
STOCK
Exchange:NASDAQ
Ticker:MEDP
Market Cap:$13.32B-$17.41B
PIPELINE
Stage:N/A (Service Provider - Not Drug Development)
Lead Drug Stage:N/A
Modalities:Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, Phase IV Post-Marketing Studies, Regulatory Affairs & Submissions, Data Management, Bioanalytical Laboratory Services, Clinical Imaging Services, Electrocardiography Services
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Long-term partnerships with major pharmaceutical companies, Relationships with major biotech firms, Medical device manufacturers
COMPETITION
Position:Challenger/Mid-Sized Leader
Competitors:IQVIA, ICON, Parexel, Labcorp Drug Development, Syneos Health, PPD, PRA Health Sciences
LEADERSHIP
Key Executives:
August J. Troendle, MD - Founder, CEO, Chairman
Jesse Geiger - President & Chief Operating Officer
David Orloff - Senior Vice President, Medical & Regulatory Affairs
Diane Sahr - Vice President, Clinical Affairs (Medical Devices)
Stephen Ewald - General Counsel, Chief Compliance Officer, Corporate Secretary
Scientific Founders:August J. Troendle, MD
Board Members:August J. Troendle, MD (Chairman)
LINKS
Website:medpace.com
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Medpace Holdings, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Medpace Holdings, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.